Advertisement

PentaVision

Optometric Management

Article

LEADING OFF: Also Notable

Optometric Management July 1, 2022 Vol 57, Issue July 2022 Page(s): 16, 18
  • Abyde, a compliance solution provider, and eye care software developer Eyefinity, a VSP Vision company, have announced their continued and expanded partnership for 2022. The two companies say they aim to continue to develop further integration of the two products and an increase in educational resources for eye care providers.
  • Aerie Pharmaceuticals, Inc. announced that the first participant in the first of three phase 3 clinical trials has been dosed with the company’s AR-15512 ophthalmic solution for the signs and symptoms of dry eye disease. Aerie says it plans to start the other two trials in the second half of 2022 in support of a potential New Drug Application (NDA) filing in 2024.
  • Registration is now open for the American Academy of Optometry’s 2022 meeting in San Diego. Academy 2022 will be held Oct. 26 to Oct. 29 at the San Diego Convention Center, and will feature more than 300 hours of education for attendees. More information and registration can be found at https://aaopt.org/events/annual-meeting/ .
  • Bausch + Lomb launched its Revive family of customizable soft contact lenses, available in spherical, toric, multifocal, and multifocal toric options. They are designed to meet the vision needs of an increased number of patients, including those who have high or unique prescriptions. For more information on the custom lenses, visit bauschsvp.com/lenses/revive-custom-soft-lenses/
  • Biogen and Samsung Bioepis plan to launch the biosimilar BYOOVIZ (ranibizumab-nuna) in the US this summer. BYOOVIZ has been approved by the FDA for the treatment of neovascular (wet) AMD, macular edema following retinal vein occlusion, and myopic choroidal neovascularization.
  • Bruder released new research highlighting the willingness of cataract surgery patients to adhere to pre-operative prep. The report found that fear is the predominant emotion in one out of three study patients; the authors strongly recommended prescribing a pre-surgical prep-kit as a way to combat fear and uncertainty. The full study, published in Clinical Ophthalmology, can be read at dovepress.com/articles.php?article_id=74206 .
  • A Centre for Ocular Research and Education (CORE) and University of Waterloo Department of Chemical Engineering study has determined that human coronaviruses can easily be removed from contact lens surfaces, although regimen matters depending on the type of lens care solution. Most notably, rub and rinse steps are crucial for non-oxidative systems, while products containing hydrogen peroxide and povidone-iodine removed contaminants through soaking alone. The complete paper and supplementary data are available from Contact Lens and Anterior Eye at https://doi.org/10.1016/j.clae.2022.101719 . The study was funded by Ophtecs Corp.
  • The Contact Lens Institute shared consumer research that reinforced the importance of communication between eye care practitioners and their patients. The research was discussed among U.S. optometrists in a video titled “Revealed! New Consumer Data Shows What’s Holding Back Your Contact Lens Practice;” the video can be viewed at https://bit.ly/CLIOnDemand22 .
  • CooperVision Specialty Eyecare announced the latest iteration of its “Make a Difference” program. The program now entering its third year, provides U.S. and Canadian optometry students and educators with the opportunity to fit patients who lack financial resources with CooperVision Specialty EyeCare’s iSee, Onefit, and Paragon CRT specialty contact lenses. More information about the program can be found at https://bit.ly/MakeADifferenceSEC .
  • EssilorLuxottica launched the OneSight EssilorLuxottica Foundation, marking a new chapter in the group’s journey to help everyone in the world “see more and be more,” the company says. The OneSight EssilorLuxottica Foundation unites many of the group’s global advocacy and philanthropic actions and will raise awareness on the importance of good vision and supporting the creation of sustainable vision care through philanthropic grants, according to the press release.
  • Haag-Streit launched its fourth Slit-Lamp Imaging Competition, to give eye care professionals across the globe an opportunity to showcase their slit lamp imaging skills. Judging criteria will include image quality, technical execution, and disease interest. the winner of the competition will also be featured in an ophthalmic journal and will receive a Sony Alpha 7 IV Kit (28-70 mm, 33 Mpx, Full frame). Prizes will also be available for second and third place. For more information, go to haag-streit.com/imaging-competition .
  • Johnson & Johnson Vision received FDA clearance for its latest daily disposable contact lenses, the ACUVUE OASYS MAX 1-Day and ACUVUE OASYS MAX 1-Day MULTIFOCAL. Available in spherical and multifocal, ACUVUE OASYS MAX 1-Day contact lenses are designed to address multiple vision correction needs. The new lenses are anticipated to be made available in the US, Canada and multiple European countries in the autumn, according to the company. For more information, visit jnjvisionpro.com/oasys-max-family .
  • Olleyes Inc. announced a partnership with eye-tracking technology company Tobii to incorporate advanced eye tracking features within the Olleyes VisuALL ETS virtual reality platform for assessment of visual functions. The Olleyes VisuALL tests collect data by projecting stimuli on specific areas of the retina as a user interacts with the device’s software. By utilizing the eye tracking, the VisuALL ETS stimulus remains consistent with the same region of the retina regardless of user error.
  • Professional Eye Care Associates of America (PECAA) held its annual meeting in Palm Springs, Calif., from May 19 to May 21, with the show returning after a three-year hiatus. This was also the first show PECAA hosted since its merger with Healthy Eyes Advantage HEA. The show saw more than 900 members, strategic vendor partners, and industry thought leaders in attendance.
  • Transitions Optical’s 25th Transitions Academy was held June 1 through 4 in Orlando. Attendees learned about Transitions’ latest projects and participated in professional development and product technology seminars, as well as heard from experts and educators on industry trends.
  • Treehouse Eyes announced it is partnering with Johnson & Johnson Vision on a direct-to-parent marketing campaign in several U.S. cities. The campaign launched in April, and includes paid social influencer partnerships, and media partnerships targeting parents, to drive awareness and a call to action to ask their eye care practitioner about myopia treatment options.
  • Vision Expo West organizers are now accepting submissions for Innovation Stage speakers, presentations, and panels. Vision Expo West will take place Sept. 14 to Sept. 17, 2022 in Las Vegas. The deadline to submit applications is July 15, and applications can be submitted at https://west.visionexpo.com/en-us/forms/innovation-stage-panel-presentation-application.html .
  • Visioneering Technologies, Inc., (VTI) has added New Era/e-dr. as the company’s latest authorized distributor for the NaturalVue (etafilcon A) Brand 1 Day Contact Lenses. All new orders for NaturalVue brand products can be placed directly through one of several options, including: Ordering online at www.e-dr.com ; by fax at (800) 338-9380; ordering by phone or speaking directly to a New Era/e-dr. customer service representative at (800) 540-0337; or using LenScan to point, scan and click to upload orders directly to your shopping cart.

What to Read Next